Surrozen Inc Cash Flow Conversion Efficiency
Surrozen Inc cash flow conversion efficiency. Based on the latest financial reports, Surrozen Inc (SRZN) has a cash flow conversion efficiency ratio of 0.034x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.42 Million) by net assets ($-218.66 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Surrozen Inc (2019–2025)
Cash flow conversion efficiency of Surrozen Inc from 2019 to 2025. This chart illustrates how Surrozen Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SRZN stock price and chart for real-time trading data and today's change.
Surrozen Inc Cash Flow Conversion Ratio Explained
Surrozen Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Surrozen Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Surrozen Inc ranked by their cash flow conversion efficiency. Also see SRZN market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CS Disco LLC
NYSE:LAW
|
-0.094x |
|
Bank Of Princeton
NASDAQ:BPRN
|
0.045x |
|
ThredUp Inc
NASDAQ:TDUP
|
0.073x |
|
Apartment Investment and Management Co
NYSE:AIV
|
0.005x |
|
COG Financial Services Ltd
AU:COG
|
0.198x |
|
Jena Acquisition Corporation II
NYSE:JENA
|
-0.001x |
|
Eisen- und Hüttenwerke AG
F:EIS
|
-0.010x |
|
Lanzhou Zhuangyuan Pasture Co Ltd
SHE:002910
|
0.059x |
Annual Cash Flow Conversion Efficiency for Surrozen Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Surrozen Inc from 2019 to 2025. Review free cash flow generation of Surrozen Inc to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-187.76 Million | $-30.24 Million | 0.161x | -80.46% |
| 2024-12-31 | $-21.38 Million | $-17.63 Million | 0.825x | +177.49% |
| 2023-12-31 | $37.94 Million | $-40.36 Million | -1.064x | -83.18% |
| 2022-12-31 | $76.00 Million | $-44.15 Million | -0.581x | -30.54% |
| 2021-12-31 | $109.70 Million | $-48.81 Million | -0.445x | +27.68% |
| 2020-12-31 | $47.29 Million | $-29.10 Million | -0.615x | +14.13% |
| 2019-12-31 | $29.39 Million | $-21.06 Million | -0.717x | -- |
About Surrozen Inc
Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, … Read more